| Tag | Content |
|---|
EnhancerAtlas ID | HS092-14030 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr13:24373290-24375380 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFE2L1 | MA0089.2 | chr13:24374742-24374757 | GAGTGACTCAGCATG | + | 6.28 | | Nfe2l2 | MA0150.2 | chr13:24374740-24374755 | CAGAGTGACTCAGCA | + | 7.73 | | Zfx | MA0146.2 | chr13:24373708-24373722 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_32683 | chr13:24373123-24375463 | GM12878 | | SE_52157 | chr13:24373443-24375859 | Skeletal_Muscle_Myoblast | | SE_59594 | chr13:24350159-24386870 | Ly3 | | SE_63961 | chr13:24373364-24375898 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr13 | 24373900 | 24374011 | | chr13 | 24374862 | 24374992 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I023799 | chr13 | 24373271 | 24375783 |
|
Enhancer Sequence | TACCACCACG CGCAGCTGAT TTTTTTTTTT TGTATTTTAG TAGAGACAGG GTTTCACCAT 60
GTTGCCCAGG CTGGTTTCGA ACTCCTAAGC TCAGGCAATC CGCCCACCTC GGCCTCCCAA 120
AGTGCTAGGA TTACAGGCAT GAGCCACCAC ACCCAGGCAA ATTAGAGTAA TTTTTTTGTT 180
TTTGTTTTTG TTTTGGGACG GAGTCTCACT CTGTCGCCCA GGCTGGAGTG CAGTGGTGCG 240
ATGTGGGCTC ACTGCAAGCT CCGCCTTCTG GGTCACGCCA TTCTTCTGCC TCAGCCTCCC 300
AAGTAGCTGG GGCTACATGC GCCCGCCACC ACGCCTGGCT AATTTTTTGT ATTTTTAGTA 360
GAGATGGGGT TTCACCGTGT TAGCCAGGAT GGCCTGGATC TCCTGACCTC ATGGTCCGCC 420
CGCCTCGGCC TCCCAAAGTG CTGGGATTAC AGGCATGAGC CACTGCGCCC GGCCTAGGAT 480
AATTTTTAAC TAATGCTAAC ACGGTGTCAC TATAATATGC CAGTTTGTTG CTGGATGCAA 540
AAATAAAACC CTAAACGTGG AGTGAATCCT ATTCACAAGA AACATGTCTT CTTTTCATAT 600
TCTTTGTTGG TGTTTGTTCT AACGAGAAGG ACCAAATATC AACATATCCT TCAGTCCCAG 660
TAACTGCTTT CCTAAAATAA CTTTTTCATT CTAGCTTTGA ACAACTTTTA TGCCATCAAG 720
ATGGTGAATT TTAAATTGTG AGTTGTGAAG AAAGACAATT TTCTTAGACG TATTATTATA 780
TTTTCATGTA AATACTTAGA GTGCTCAGAA CTTTCTTATT CTGTTTTCAA TTTGAGGTCA 840
CTAAAGGGCA AAAAGGAGTC TCACTGGTGG CAAGATTTAT TCAGAGAACA CTGTCACTCT 900
GAGAACAGCT GTGCTGGAGA CACAGCCTCA CCACCCAAAC CCACAAGCCT ACCAAATTAG 960
GTCAAAACAC TAAAATACAA CTGCTTAACA GATCTTCAAA ACCTAGAGTC AGCTGTTCAT 1020
GTTTTGTACT TGAAAAATAC ACATTAGAAC AGAGTCAGAG GATCAAAGGC TAGAAGTTTC 1080
ATCCCAGAGC TTTCTGGACA CGACTGTATC TCAACTGTGT CAGAGAGGAG GGTGAAAATG 1140
TAAAATTACA AACCTAGAAT GCTACAAAAA TAAAAATATT ACATTTTCTA TTTCCTGAAT 1200
TAAAAATAGG AGAGATACAC AATCGCTTAG GGAAAATATT CTGAGAAGAG ACAGTCATGA 1260
ATATAAAAAA CACAACAACA CAACACTGTT CTCTAAATGG AAGAGAAGTG GTAACAGCAG 1320
AAGGTGAGCC TGTTGGTATA TGTTGTACTA TTGCCCTCTA TTCACAAATG AGTAGAAAAT 1380
TTTGGATTTC CAGCATCAAA CTACTGTTAG ATGGAATAGC AAGTAAGTAC AAATTAGCCT 1440
ATATTTTATA CAGAGTGACT CAGCATGCAC ACAAATATCA ATAAATTGCC GACACTAGAA 1500
GGCTATTTAT TGACTTGTAA AGAAAGCATC ATTATTTAAT ATGGAATATC TGTGGAGCTG 1560
CCCCTATTAA ATAGTTACAG TCATGTAAAT GCAATTTTCC AAAGTATGAC CTACATAAAG 1620
CTAGTGCCTA GAAATTATCC ATGAAGACTT CCAGGGTTAA TACATTTGAG GATAGAGACT 1680
CATAATGTTT GTTAGCATAT TACAGACTCC AAGCGGTTCC TCAGTAGAGA AGCCAGCTCA 1740
ATGTTGTTTA AACCAGTATT GCTCAAAGAT AACTAGTGCG ACACTTTATT CCCAAGATGA 1800
GTTATTAATG CACTTAAAGA ATTGCTAATA TAGACATATG CAAAATCACT GTCTAAAAGT 1860
TTGTACCAGA TTATGTACCT AAATTTGTAT CAACTCCATA AGCATTATAA AGACTCTTCG 1920
TTGCTTATAT TTTCCTTTTC TCATTGTTTA ATTTGGGGGA ATAAAAGGAT TCATTTCAGA 1980
GAAACAATTT CTGGAGACAA GTTTACAGGG GGAACACTGT CACTCTTTGG CCCGCATGGG 2040
AAGGCGCTAC AAAGTCATCT TCTATCCGAT ATGGAAGTTG AAAGCCTTGC 2090
|
